ProShare Advisors’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12,357
Closed -$29.5K 1945
2025
Q4
$29.5K Buy
12,357
+793
+7% +$2.17K ﹤0.01% 2001
2025
Q3
$33K Sell
11,564
-2,305
-17% -$7.89K ﹤0.01% 1964
2025
Q2
$52.3K Buy
13,869
+915
+7% +$3.6K ﹤0.01% 1988
2025
Q1
$58.7K Sell
12,954
-3,900
-23% -$20.6K ﹤0.01% 1929
2024
Q4
$119K Buy
16,854
+5,815
+53% +$46.3K ﹤0.01% 2037
2024
Q3
$89.9K Buy
+11,039
New +$79.8K ﹤0.01% 1898
2024
Q2
Sell
-10,259
Closed -$77.2K 1913
2024
Q1
$77.2K Buy
+10,259
New +$93.6K ﹤0.01% 1858
2022
Q2
Sell
-9,802
Closed -$256K 1938
2022
Q1
$256K Sell
9,802
-1,615
-14% -$45.8K ﹤0.01% 1748
2021
Q4
$453K Buy
11,417
+4,989
+78% +$227K ﹤0.01% 1530
2021
Q3
$321K Sell
6,428
-5,170
-45% -$282K ﹤0.01% 1495
2021
Q2
$644K Buy
11,598
+2,608
+29% +$139K ﹤0.01% 1348
2021
Q1
$420K Buy
8,990
+1,539
+21% +$74.5K ﹤0.01% 1558
2020
Q4
$324K Buy
+7,451
New +$275K ﹤0.01% 1559

Other funds holding HCAT